R&D Systems™ Recombinant Human PDGF-AA Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 221AA01M

Catalog No. 22-1AA0-1M

Description

The Recombinant Human PDGF-AA Protein is derived from E. coli. The Recombinant Human PDGF-AA Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P04085
• Formulation: Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA. *1 mg pack size (01M) is supplied as a 0.2 μm filtered solution in Acetonitrile and TFA.
• Molecular Weight (g/mol): M.W. theroretical: 14 kDa (monomer)
• Source: <EM>E. coli</EM>-derived human PDGF-AA protein Ser87-Thr211, with and without an N-terminal Met
• Regulatory Status: RUO
• Gene Alias: PDGF1, PDGF-A, PDGFAA
• Conjugate: Unconjugated
• Species: Human
• Buffer: Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.

• For Use With (Application): Bioactivity
• Gene ID (Entrez): 5154
• Quantity: 1000 μg
• Storage Requirements: Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution
• Endotoxin Concentration: <0.01 EU per 1 μg of the protein by the LAL method.
• Gene Symbol: PDGFA
• Cross Reactivity: PDGF-AA
• Reconstitution: Reconstitute at 100 μg/mL in sterile 4 mM HCl.
• Purity or Quality Grade: >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.